ALFREDO TORRES: Open Payments
NPI 1033178975 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,978 in 95 payments from 13 companies in 2025. Trend: 2023 $2,233 · 2024 $1,457 · 2025 $3,978
Food & beverage: $2,309Consulting: $1,650Education: $19
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 1 | $1,650 |
| Neurocrine BioSciences, Inc. | 19 | $672 |
| ACADIA Pharmaceuticals Inc | 17 | $265 |
| Otsuka America Pharmaceutical, Inc. | 6 | $255 |
| Lundbeck LLC | 10 | $217 |
| Vanda Pharmaceuticals Inc. | 6 | $197 |
| E.R. Squibb & Sons, L.L.C. | 12 | $167 |
| Alkermes, Inc. | 9 | $164 |
| Janssen Pharmaceuticals, Inc | 6 | $142 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
Products named: INGREZZA, REXULTI, NUPLAZID, FANAPT, COBENFY, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across LA — which companies pay providers there.
